Rethinking drug design in the artificial intelligence era
ETH Zurich · Relay Therapeutics (United States) · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
843
total citations
- FWCI
- 65.70
- Percentile
- 100%
- References
- 204
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Drug discovery
- Skepticism
- Data science
- Computer science
- Engineering ethics
- Engineering
- Epistemology
- Bioinformatics
UN Sustainable Development Goals
- Industry, innovation and infrastructure
No related works found for this paper.